Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05903859 · ClinicalTrials.gov registry record · Phase 3

Improvement of Reproductive Function in Men With Spinal Cord Injury (SCI)

A Phase 3 study of Infertility, Male, sponsored by University of Miami.

Recruiting
Registry status
Phase 3
Development phase
90
Enrollment target
1
Study location

NCT05903859 is a Phase 3 study of Infertility, Male that is actively recruiting participants, run by University of Miami. The registered enrollment target is 90 participants, below the 566-participant average among 8 other Infertility, Male trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05903859, a Phase 3 study of Infertility, Male, is actively recruiting participants, sponsored by University of Miami.

RECRUITING
Registry status
Phase 3
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

This is a study of infertility which often occurs in men with spinal cord injury. Most men with spinal cord injury have a normal sperm count but abnormally low sperm motility - which means that the sperm does not swim well. This study will determine if a medicine given by mouth will improve sperm motility in men with spinal cord injuries. The medicine is called probenecid.

Conditions Studied

Interventions

  • DRUG Placebo
  • DRUG Probenecid 500 Milligrams (mg)
  • DRUG probenecid 250 Milligrams (mg)

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2024-01-18
Est. Completion 2028-12-31
Phase Phase 3

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT05903859

The ClinicalTrials.gov registry entry for NCT05903859 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 566-participant average among 8 other Infertility, Male trials with a reported enrollment target (84% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Infertility, Male appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT05903859 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05903859 about?

NCT05903859 is a clinical study titled "Improvement of Reproductive Function in Men With Spinal Cord Injury (SCI)". This is a study of infertility which often occurs in men with spinal cord injury. Most men with spinal cord injury have a normal sperm count but abnormally low sperm motility - which means that the sperm does not swim well. This study will determine if a medicine given by mouth will improve sperm mo...

What is the current status of trial NCT05903859?

This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 90 participants. The study started on 2024-01-18. Estimated completion is 2028-12-31.

What conditions does trial NCT05903859 study?

This clinical trial studies the following conditions: Infertility, Male.

What interventions are being tested in trial NCT05903859?

The interventions under investigation include: Placebo (DRUG), Probenecid 500 Milligrams (mg) (DRUG), probenecid 250 Milligrams (mg) (DRUG).

Who is sponsoring clinical trial NCT05903859?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05903859 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infertility, Male

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.